PEDIATRICS Vol. 99 No. 2 February 1997, pp. 226-231 (doi:10.1542/peds.99.2.226)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoeman, J. F.
Right arrow Articles by Donald, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoeman, J. F.
Right arrow Articles by Donald, P. R.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 99 No. 2 February 1997, pp. 226-231

Effect of Corticosteroids on Intracranial Pressure, Computed Tomographic Findings, and Clinical Outcome in Young Children With Tuberculous Meningitis

Received Nov 10, 1995; accepted Mar 14, 1996.

Johan F. Schoeman, Lana E. Van Zyl, Jacoba A. Laubscher, and Peter R. Donald

From the Department of Paediatrics and Child Health, Faculty of Medicine, University of Stellenbosch and Tygerberg Hospital, Tygerberg, Republic of South Africa; and CERSA, Division of Biostatistics, Medical Research Council, Parow-Valley, Republic of South Africa.

Objective.  To study the effect of high-dose prednisone on intracranial pressure (ICP), cranial computed tomographic (CT) findings, and clinical outcome in young children with moderate to severe tuberculous meningitis (TBM).

Study Design.  Prospective, controlled, randomized study.

Methods.  Continuous lumbar cerebrospinal fluid pressure monitoring and contrasted CT scanning were performed in 141 consecutive children with TBM at admission. All children were then randomly allocated to a nonsteroid group (71 children) or a steroid group (70 children) who received prednisone (first 16 children, 2 mg/kg per day; next 54 children, 4 mg/kg per day) for the first month of treatment. ICP monitoring and CT scanning were repeated regularly, and clinical outcome was assessed after 6 months of antituberculosis treatment.

Results.  No statistically significant difference in ICP or the degree of hydrocephalus (as demonstrated by CT scan) was found between the steroid and nonsteroid groups after the first month of treatment. Basal ganglia infarcts developed in 16% of children in the steroid group and 24% in the nonsteroid group during the first month of treatment. Neither this incidence nor the eventual size of infarcts present at admission differed significantly between the two treatment groups. Single or multiple tuberculomas were seen on the first CT scans of 7 children (5%), whereas tuberculomas developed in 11 children (8%) at treatment. Both the response of the tuberculomas to treatment and the incidence of new tuberculomas were significantly improved by steroid therapy. Basal enhancement was also significantly less in the steroid group after 1 month of treatment. Steroids lowered mortality in stage III TBM significantly. Similarly, more surviving children in the steroid group had IQs of greater than 75 than did the those in the nonsteroid group. No significant difference was found in the incidence of motor deficit, blindness, or deafness.

Conclusions.  Corticosteroids significantly improved the survival rate and intellectual outcome of children with TBM. Enhanced resolution of the basal exudate and tuberculomas by steroids was shown by serial CT scanning. Corticosteroids did not affect ICP or the incidence of basal ganglia infarction significantly.

Key words: corticosteroids, tuberculous meningitis, intracranial pressure, computed tomography, clinical outcome.




This article has been cited by other articles:


Home page
 Arch Intern MedHome page
S. McGee and J. Hirschmann
Use of Corticosteroids in Treating Infectious Diseases
Arch Intern Med, May 26, 2008; 168(10): 1034 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. B. Rock, M. Olin, C. A. Baker, T. W. Molitor, and P. K. Peterson
Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects
Clin. Microbiol. Rev., April 1, 2008; 21(2): 243 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. J. Marais, R. P. Gie, H. S. Schaaf, N. Beyers, P. R. Donald, and J. R. Starke
Childhood Pulmonary Tuberculosis: Old Wisdom and New Challenges
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1078 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
J. F. Schoeman, G. Fieggen, N. Seller, M. Mendelson, and B. Hartzenberg
Intractable Intracranial Tuberculous Infection Responsive to Thalidomide: Report of Four Cases
J Child Neurol, April 1, 2006; 21(4): 301 - 308.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
C. P. Simmons, G. E. Thwaites, N. T. H. Quyen, T. T. H. Chau, P. P. Mai, N. T. Dung, K. Stepniewska, N. J. White, T. T. Hien, and J. Farrar
The Clinical Benefit of Adjunctive Dexamethasone in Tuberculous Meningitis Is Not Associated with Measurable Attenuation of Peripheral or Local Immune Responses
J. Immunol., July 1, 2005; 175(1): 579 - 590.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. J. Seligman, A. G. Vagenakis, V. Kyriazopoulou, T. K. Marras, G. E. Thwaites, H. T. Quy, J. J. Farrar, and V. Quagliarello
Dexamethasone for Tuberculous Meningitis
N. Engl. J. Med., February 10, 2005; 352(6): 628 - 630.
[Full Text] [PDF]

Home page
 NEJMHome page
G. E. Thwaites, N. D. Bang, N. H. Dung, H. T. Quy, D. T. T. Oanh, N. T. C. Thoa, N. Q. Hien, N. T. Thuc, N. N. Hai, N. T. N. Lan, et al.
Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults
N. Engl. J. Med., October 21, 2004; 351(17): 1741 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
J. F. Schoeman, P. Springer, A. J. van Rensburg, S. Swanevelder, W. A. Hanekom, P. A. J. Haslett, and G. Kaplan
Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized Study
J Child Neurol, April 1, 2004; 19(4): 250 - 257.
[Abstract] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. Tsenova, B. Mangaliso, G. Muller, Y. Chen, V. H. Freedman, D. Stirling, and G. Kaplan
Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1887 - 1895.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
F J Kirkham
Non-traumatic coma in children
Arch. Dis. Child., October 1, 2001; 85(4): 303 - 312.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
J. F. Schoeman, P. Springer, A. Ravenscroft, P. R. Donald, L.-G. Bekker, A. J. van Rensburg, W. A. Hanekom, P. A. J. Haslett, and G. Kaplan
Adjunctive Thalidomide Therapy of Childhood Tuberculous Meningitis: Possible Anti-Inflammatory Role
J Child Neurol, August 1, 2000; 15(8): 497 - 503.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
P. K. Coyle
Glucocorticoids in Central Nervous System Bacterial Infection
Arch Neurol, July 1, 1999; 56(7): 796 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
R. K. Garg
Classic diseases revisited: Tuberculosis of the central nervous system
Postgrad. Med. J., March 1, 1999; 75(881): 133 - 140.
[Abstract] [Full Text]

Home page
 PediatricsHome page
A. Yaramis, F. Gurkan, M. Elevli, M. Söker, K. Haspolat, G. Kirbas, and M. A. Tas
Central Nervous System Tuberculosis in Children: A Review of 214 Cases
Pediatrics, November 1, 1998; 102(5): 49e - 49.
[Abstract] [Full Text]

Home page
 ThoraxHome page
Joint Tuberculosis Committee of the British Thorac
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998
Thorax, July 1, 1998; 53(7): 536 - 548.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
A. Bonington, J. I. G. Strang, P. E. Klapper, S. V. Hood, W. Rubombora, M. Penny, R. Willers, and E. G. L. Wilkins
Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in Early Diagnosis of Tuberculous Meningitis
J. Clin. Microbiol., May 1, 1998; 36(5): 1251 - 1254.
[Abstract] [Full Text]